Henry Clement Pitot
Mayo Clinic · 741 works · 41,598 citations · h-index 88
Top works
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer
- A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
- Primary culture of parenchymal liver cells on collagen membranes
- Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
- Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
- Enzyme levels in rats adapted to 36-hour fasting
- The stages of initiation and promotion in hepatocarcinogenesis
- METABOLIC REGULATORY CIRCUITS AND CARCINOGENESIS.
- Improved assay of 3-hydroxy-3-methylglutaryl coenzyme A reductase
- Use of a low-speed, iso-density percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations
- Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer
- Pathology of mouse models of intestinal cancer: Consensus report and recommendations
- Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine.
- The comparative enzymology and cell origin of rat hepatomas. I. Deoxycytidylate deaminase and thymine degradation.
- Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine
- Metabolic adaptations in rat hepatomas. I. The effect of dietary protein on some inducible enzymes in liver and hepatoma 5123.
- Fetal phenotypic expression by adult rat hepatocytes on collagen gel/nylon meshes.
- 3′,5′-cyclic AMP and the release of polysone-bound proteins in vitro
- Studies on the Induction and Repression of Enzymes in Rat Liver